Dallan Murray

Dallan Murray

Former Executive Vice President, Chief Customer OfficeratSarepta Therapeutics· In proxies 2022–2025

Pay in FY2025+3% from the year before · Sarepta Therapeutics stock -82.3% the same year

Dallan Murray was paid $2.7M in FY2025 (Dec), up 3%. Sarepta Therapeutics stock fell 82.3% that year.

Pay$100 in the stock at the end of FY21 → $24
Pay is from the Summary Compensation Table of each Sarepta Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sarepta TherapeuticsPublic company · 4 yr
    • Former Executive Vice President, Chief Customer Officer2022 – Present · 4 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?